期刊文献+

氟伏沙明和氯丙咪嗪治疗儿童少年强迫症的对比研究 被引量:3

Control Study of Fluvoxamine and Chlormipramine in Treatment of Child-Adolescence Obsession
下载PDF
导出
摘要 目的:了解氟伏沙明治疗儿童少年强迫症的疗效和安全性。方法:用CCMD-3作为诊断标准,将在我院诊断明确的8~16岁的60例儿童少年强迫症患者随机分成2组,分别给予氟伏沙明和氯丙咪嗪治疗,共观察8周,采用Y?BOCS和TESS量表评定临床疗效和药物不良反应。结果:氟伏沙明治疗儿童少年强迫症的总有效率为90%,氯丙咪嗪治疗儿童少年强迫症的总显效率为86.7%,两者无显著性差异;氟伏沙明不良反应发生率33.3%,氯丙咪嗪不良反应发生率70%,两者有显著性差异,且氟伏沙明的不良反应较轻。结论:氟伏沙明对儿童少年强迫症的治疗有很好的疗效,且不良反应少。 Objective:To observe the effects and security of Fluvoxamine and Chlormipramine in treating patients with Child - Adolescence Obsession. Methods: According to CCMD - 3, 60 patients with Child - Adolescence Obsession were randomly divided into Fluvoxamine and Chlormipramine group. The duration of treatment was 8 weeks. Yale - Brown scale and Tess were used to evaluate the efficacy and adverse effects respectively. Results : The effective rates of Fluvoxamine group and Chlormipramine were 90% and 86. 7%, which showed no significant difference between the two groups. The occurred rate of adverse effects of Fluvoxamine group and Chlormipramine were 33.3% and 70%, which showed significant difference between the two groups. Conclusions: Fluvoxamine has good efficacy in treating Child - Adolescence Obsession, but has less adverse effects.
出处 《中国民康医学》 2007年第11期438-438,440,共2页 Medical Journal of Chinese People’s Health
关键词 儿童少年 强迫症 氟伏沙明 氯丙眯嗪 Child- Adolescence Obsession Fluvoxamine Chlormipramine
  • 相关文献

参考文献10

二级参考文献62

  • 1童慧琦,徐俊冕,周云.抑郁障碍中抑郁、绝望与自杀行为研究[J].中国心理卫生杂志,1996,10(2):84-86. 被引量:7
  • 2杨权.选择性5-羟色胺重摄取抑制剂治疗抑郁症研究进展[J].岭南精神医学杂志,2000,2:124-124. 被引量:2
  • 3[1]Yasui FN, Kondo T, Mihara K, et al. Fluvoxamine dose-dependent interaction with haloperidol and the effects on negative symptoms in schizophrenia [ J ]. Psychopharmacology ( Berl ),2004,171(2) :223 - 227. 被引量:1
  • 4[2]Kanda H, Yasui FN, Fukasawa T, et al. Interaction study between fluvoxamine and quazepam[J]. J Clin Pharmacol, 2003 , 4 3 (12 ) :1392 - 1397. 被引量:1
  • 5[3]Stein DJ,Westenberg HG,Yang H,et al. Fluvoxamine CR in the long-term treatment of social anxiety disorder: the 12-to 24-week extension phase of a multicentre, randomized, placebo-controlled trial[J]. Int J Neuropsychopharmacol,2003,6(4) :317 - 323. 被引量:1
  • 6[4]Zanardi R, Cusin C, Rossini D, et al. Comparison of response to fluvoxamine in nondemented elderly compared to younger patients affected by major depression[J ]. J Clin Psychopharmacol, 2003,23(6) :535 - 539. 被引量:1
  • 7[5]Dalery J, Honig A. Fluvoxamine versus fluoxetine in major depressive episode: a double-blind randomized comparison[ J ]. Hum Psychopharmacol,2003,18(5): 379 - 384. 被引量:1
  • 8[6]Hollander E,Koran LM, Goodman WK, et al. A double-blind,placebo-controlled study of the efficacy and safety of controlledrelease fluvoxamine in patients with obsessive-compulsive disorder [J] .J Clin Psychiatry,2003,64(6) :640 - 647. 被引量:1
  • 9[7]Silver H, Aharon N, Kaplan A. Add-on fluvoxamine improves primary negative symptoms: evidence for specificity from response analysis of individual symptoms [ J ]. Schizophr Bull, 2003, 29(3):541-546. 被引量:1
  • 10Riddle M. Obsessive-compulsive disorder in children and adolescents [J]. Br J Psychiatry ,1998 , 35 (Suppl) :91 -96. 被引量:1

共引文献48

同被引文献59

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部